← All trials
NCT05717790
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2022
- Primary completion
- Nov 30, 2024
- Completion date
- Nov 30, 2027
- First posted
- Feb 8, 2023
- Last posted
- Feb 8, 2023
- Enrollment
- 288
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Guangxi Medical UniversityLead sponsor
- Youjiang Medical UniversityCollaborator
- Guilin UniversityCollaborator
- Nanxishan Hospital of Guangxi Zhuang Autonomous RegionCollaborator
- People's Hospital of BaiseCollaborator
- Guangzhou Medical UniversityCollaborator
- Wuzhou Red Cross HospitalCollaborator
- Guangxi Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.